StemZyme is one of the most unique treatments out there because it can tackle so many different concerns at once—from dark ...
The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need to devise approaches to mitigate it. However, the molecular mechanisms ...
Lynk received the green light from the FDA to begin clinical trials of its investigational oral therapy LNK01006 for MS and other diseases.
A review article discussed the expanding role of biologics in treating components of metabolic syndrome, including glucagon-like peptide 1 (GLP-1) analogs for type 2 diabetes and obesity and ...
Researchers at Helmholtz Munich, the Technical University of Munich and the LMU University Hospital Munich uncovered a ...